IASO Biotherapeutics is a biopharmaceutical company. The nanjing-based company closed a Series C financing round of $108 million.
AccuRx raised $38 million in a Series B funding round. The company has now raised a total of $49.9 million to date.
HexaHealth is a health tech startup. The startup picks up $1.5 million from eight investors in Seed funding.
Previous page Next page